Search
CRISPR Therapeutics AG
CRSPAdd to Watchlist
47.640USD
+0.090+0.19%
Close 07-29 16:00（ET）Quotes delayed by 15 min
4.59BMarket Cap
LossP/E TTM
CRISPR Therapeutics AG's Company Valuation
Currency: USD Updated: 2026-07-29The current valuation score of CRISPR Therapeutics AG is 8.49, ranking 121 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.73, which is -100.00% below the recent high of 0.00 and -494.78% above the recent low of -45.96.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.